ImmunoQure AG and Memo Therapeutics AG announce collaboration for the production of APS-1 cognate, paired libraries
ImmunoQure AG, a biotechnology company focused on the development of autoantibodies as therapeutics to treat human diseases today announced the publication of data in the leading scientific journal Frontiers in Immunology.